"Item","Total","Cards","PCPs","Nephs","Endos","Lipids","HCP","NP/PA","Higher","Lower","Tier 1","Tier 2","Tier 3","Tier 4","Segment A","Segment B","Segment C","Segment D","Priority Account","Non-Priority Account"
"Leqvio (inclisiran)","94 (62.3%)","0 (0%)","32 (64%)","0 (0%)","1 (10%)","2 (20%)","77 (53.8%)","7 (87.5%)","47 (61.8%)","47 (62.7%)","20 (58.8%)","50 (65.8%)","19 (54.3%)","5 (83.3%)","30 (61.2%)","18 (64.3%)","20 (71.4%)","25 (55.6%)","69 (61.6%)","25 (64.1%)"
"Praluent (alirocumab)","94 (62.3%)","0 (0%)","27 (54%)","0 (0%)","2 (20%)","2 (20%)","78 (54.5%)","6 (75%)","48 (63.2%)","46 (61.3%)","22 (64.7%)","45 (59.2%)","22 (62.9%)","5 (83.3%)","31 (63.3%)","15 (53.6%)","18 (64.3%)","29 (64.4%)","65 (58%)","29 (74.4%)"
"Repatha (evolocumab)","95 (62.9%)","0 (0%)","30 (60%)","0 (0%)","2 (20%)","2 (20%)","79 (55.2%)","6 (75%)","49 (64.5%)","46 (61.3%)","20 (58.8%)","49 (64.5%)","21 (60%)","5 (83.3%)","29 (59.2%)","16 (57.1%)","21 (75%)","28 (62.2%)","65 (58%)","30 (76.9%)"
"Nexletol (bempedoic acid) or Nexlizet (bempedoic acid and ezetimibe)","89 (58.9%)","0 (0%)","28 (56%)","0 (0%)","2 (20%)","2 (20%)","72 (50.3%)","6 (75%)","47 (61.8%)","42 (56%)","21 (61.8%)","43 (56.6%)","24 (68.6%)","1 (16.7%)","28 (57.1%)","16 (57.1%)","18 (64.3%)","27 (60%)","64 (57.1%)","25 (64.1%)"
